184 related articles for article (PubMed ID: 19128232)
1. Tumor growth-promoting properties of macrophage migration inhibitory factor.
Bifulco C; McDaniel K; Leng L; Bucala R
Curr Pharm Des; 2008; 14(36):3790-801. PubMed ID: 19128232
[TBL] [Abstract][Full Text] [Related]
2. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).
Mitchell RA; Bucala R
Semin Cancer Biol; 2000 Oct; 10(5):359-66. PubMed ID: 11100884
[TBL] [Abstract][Full Text] [Related]
3. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.
Asare Y; Schmitt M; Bernhagen J
Thromb Haemost; 2013 Mar; 109(3):391-8. PubMed ID: 23329140
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis.
Nishihira J; Ishibashi T; Fukushima T; Sun B; Sato Y; Todo S
Ann N Y Acad Sci; 2003 May; 995():171-82. PubMed ID: 12814949
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor: a probable link between inflammation and cancer.
Bucala R; Donnelly SC
Immunity; 2007 Mar; 26(3):281-5. PubMed ID: 17376392
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner.
Oda S; Oda T; Nishi K; Takabuchi S; Wakamatsu T; Tanaka T; Adachi T; Fukuda K; Semenza GL; Hirota K
PLoS One; 2008 May; 3(5):e2215. PubMed ID: 18493321
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
[TBL] [Abstract][Full Text] [Related]
8. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Sun B; Nishihira J; Suzuki M; Fukushima N; Ishibashi T; Kondo M; Sato Y; Todo S
Int J Mol Med; 2003 Oct; 12(4):633-41. PubMed ID: 12964047
[TBL] [Abstract][Full Text] [Related]
9. [MIF in head and neck cancer: a new therapeutic target ?].
Lechien JR; Kindt N; Costa Pde A; Chantrain G; Preillon J; Laurent G; Saussez S
Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):67-74. PubMed ID: 24683815
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.
Lolis E
Curr Opin Pharmacol; 2001 Dec; 1(6):662-8. PubMed ID: 11757824
[TBL] [Abstract][Full Text] [Related]
11. Targeting the heat shock protein 90: a rational way to inhibit macrophage migration inhibitory factor function in cancer.
Schulz R; Moll UM
Curr Opin Oncol; 2014 Jan; 26(1):108-13. PubMed ID: 24225413
[TBL] [Abstract][Full Text] [Related]
12. Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
Oghumu S; Knobloch TJ; Terrazas C; Varikuti S; Ahn-Jarvis J; Bollinger CE; Iwenofu H; Weghorst CM; Satoskar AR
Int J Cancer; 2016 Sep; 139(6):1379-90. PubMed ID: 27164411
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.
Nishihira J
J Interferon Cytokine Res; 2000 Sep; 20(9):751-62. PubMed ID: 11032394
[TBL] [Abstract][Full Text] [Related]
14. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Lue H; Kleemann R; Calandra T; Roger T; Bernhagen J
Microbes Infect; 2002 Apr; 4(4):449-60. PubMed ID: 11932196
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer.
Suresh V; Sundaram R; Dash P; Sabat SC; Mohapatra D; Mohanty S; Vasudevan D; Senapati S
Sci Rep; 2019 Oct; 9(1):15507. PubMed ID: 31664114
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation.
Petrenko O; Fingerle-Rowson G; Peng T; Mitchell RA; Metz CN
J Biol Chem; 2003 Mar; 278(13):11078-85. PubMed ID: 12538581
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.
Rendon BE; Willer SS; Zundel W; Mitchell RA
Exp Mol Pathol; 2009 Jun; 86(3):180-5. PubMed ID: 19186177
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL
J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
